论文部分内容阅读
医药信息论坛1992年6月25日载张湘茹摘译自(Cancer 1991;41(3):187)文章,苦杏仁甙(laetrile)在70～80年代曾是一种闻名遐尔的“抗癌新药”,但大量实验和由美国FDA组织的多中心严格的临床观察证明并无真正的疗效,而且在较大剂量时毒性明显。苦杏仁甙可能具有其它一些生物活性,但并无抗肿瘤作用,故苦杏仁甙作为一种抗癌药则属一种假药。苦杏仁甙原是一种从杏仁中分离出来的天然物质,可释放氰化物,故对生物可产生致死性毒性。其英文名称amygdalin。在20年代,Ernst T.krebs医生首先将该物
The Medical Information Forum on June 25, 1992 contained Zhang Xiangru’s translation (Cancer 1991; 41 (3): 187). The amygdalin (laetrile) was a famous anti-cancer drug in the 70s to 80s. ", but a large number of experiments and rigorous clinical observations organized by the FDA in the United States have proved that there is no real effect, and the toxicity is obvious at larger doses. Bitter amygdalin may have other biological activities, but it has no anti-tumor effect, so amygdalin is an anti-cancer drug as an anti-cancer drug. Bitter amygdalin is a natural substance isolated from almonds and releases cyanide, which can cause lethal toxicity to organisms. Its English name amygdalin. In the 1920s, Dr. Ernst T.krebs first